The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a promising advance. Unlike shots, this approach offers a simpler way to administer GLP-1 therapies. These https://kallumlnle247971.blogrelation.com/47585439/glp-1-patches-a-new-approach-to-blood-sugar-management